Abstract
ACQUISITION BY acquisition, Dorf Ketal Chemicals is emerging as a serious contender in the global specialty chemical market. Earlier this year, the little-known firm acquired DuPont’s specialty catalyst business, a move that will boost its sales by at least $50 million annually. The purchase was the latest in what the Indian company promises will be a long series of buys. In the pharmaceutical arena, many Indian firms have become international players. Readers of the business pages in daily newspapers know about Indian drug companies such as Piramal Healthcare or Dr. Reddy’s Laboratories. Similarly, Reliance Industries is familiar to anyone with a passing knowledge of petrochemicals. In contrast, no company from India is a well-known global producer of specialty chemicals. Dorf Ketal is on its way to assuming that mantle. Its managers tell C&EN that they are looking for additional businesses to buy and getting ready to set up manufacturing facilities and technical support centers ...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
